Toll Free: 1-888-928-9744

EMEA (Europe, Middle East and Africa) Oral Solid Dosage Pharmaceutical Formulation Market Report 2017

Published: Aug 8, 2017 | Pages: 117 | Publisher: QYResearch | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

In this report, the EMEA Oral Solid Dosage Pharmaceutical Formulation market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Oral Solid Dosage Pharmaceutical Formulation for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Oral Solid Dosage Pharmaceutical Formulation market competition by top manufacturers/players, with Oral Solid Dosage Pharmaceutical Formulation sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
    AstraZeneca Plc.
    Bristol-Myers Squibb Company
    Eli Lilly and Company
    Gilead Sciences
    Merck & Co. Inc.
    Novartis AG
    Pfizer Inc.
    AbbVie Inc.
    Boehringer Ingelheim GmbH
    Hoffman-La-Roche Ltd.
    Johnson & Johnson
    Biogen Inc.
    Bayer AG
    Teva Pharmaceticals
    Amgen Inc.
    Takeda Pharmaceutical Company Ltd.
    Otsuka Pharmaceutical Co., Ltd.
    Shire Plc.
    Celgene Corporation
    Astellas Pharma Inc.

On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
    By Form
        Capsules
        Powders
        Tablets
    By Drug Release Mechanism
        Immediate Release
        Extended Release

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K MT), market share and growth rate of Oral Solid Dosage Pharmaceutical Formulation for each application, including
    Hospitals
    Clinics
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

EMEA (Europe, Middle East and Africa) Oral Solid Dosage Pharmaceutical Formulation Market Report 2017
1 Oral Solid Dosage Pharmaceutical Formulation Overview
    1.1 Product Overview and Scope of Oral Solid Dosage Pharmaceutical Formulation
    1.2 Classification of Oral Solid Dosage Pharmaceutical Formulation
        1.2.1 EMEA Oral Solid Dosage Pharmaceutical Formulation Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Oral Solid Dosage Pharmaceutical Formulation Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Capsules
        1.2.4 Powders
        1.2.5 Tablets
    1.3 EMEA Oral Solid Dosage Pharmaceutical Formulation Market by Application/End Users
        1.3.1 EMEA Oral Solid Dosage Pharmaceutical Formulation Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Other
    1.4 EMEA Oral Solid Dosage Pharmaceutical Formulation Market by Region
        1.4.1 EMEA Oral Solid Dosage Pharmaceutical Formulation Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Oral Solid Dosage Pharmaceutical Formulation (2012-2022)
        1.5.1 EMEA Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2012-2022)

2 EMEA Oral Solid Dosage Pharmaceutical Formulation Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Oral Solid Dosage Pharmaceutical Formulation Market Competition by Players/Manufacturers
        2.1.1 EMEA Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Oral Solid Dosage Pharmaceutical Formulation Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Oral Solid Dosage Pharmaceutical Formulation Sale Price by Players (2012-2017)
    2.2 EMEA Oral Solid Dosage Pharmaceutical Formulation (Volume and Value) by Type/Product Category
        2.2.1 EMEA Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Oral Solid Dosage Pharmaceutical Formulation Sale Price by Type (2012-2017)
    2.3 EMEA Oral Solid Dosage Pharmaceutical Formulation (Volume) by Application
    2.4 EMEA Oral Solid Dosage Pharmaceutical Formulation (Volume and Value) by Region
        2.4.1 EMEA Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Oral Solid Dosage Pharmaceutical Formulation Sales Price by Region (2012-2017)

3 Europe Oral Solid Dosage Pharmaceutical Formulation (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Oral Solid Dosage Pharmaceutical Formulation Sales and Value (2012-2017)
        3.1.1 Europe Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2012-2017)
    3.2 Europe Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Type
    3.3 Europe Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Application
    3.4 Europe Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Oral Solid Dosage Pharmaceutical Formulation Sales Volume by Countries (2012-2017)
        3.4.2 Europe Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries (2012-2017)
        3.4.3 Germany Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2017)
        3.4.4 France Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2017)
        3.4.5 UK Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2017)
        3.4.6 Russia Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2017)
        3.4.7 Italy Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2017)

4 Middle East Oral Solid Dosage Pharmaceutical Formulation (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Oral Solid Dosage Pharmaceutical Formulation Sales and Value (2012-2017)
        4.1.1 Middle East Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2012-2017)
    4.2 Middle East Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Type
    4.3 Middle East Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Application
    4.4 Middle East Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Oral Solid Dosage Pharmaceutical Formulation Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2017)
        4.4.4 Israel Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2017)
        4.4.5 UAE Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2017)
        4.4.6 Iran Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2017)

5 Africa Oral Solid Dosage Pharmaceutical Formulation (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Oral Solid Dosage Pharmaceutical Formulation Sales and Value (2012-2017)
        5.1.1 Africa Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2012-2017)
    5.2 Africa Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Type
    5.3 Africa Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Application
    5.4 Africa Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Oral Solid Dosage Pharmaceutical Formulation Sales Volume by Countries (2012-2017)
        5.4.2 Africa Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries (2012-2017)
        5.4.3 South Africa Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2017)

6 EMEA Oral Solid Dosage Pharmaceutical Formulation Manufacturers/Players Profiles and Sales Data
    6.1 AstraZeneca Plc.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Oral Solid Dosage Pharmaceutical Formulation Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Bristol-Myers Squibb Company
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Oral Solid Dosage Pharmaceutical Formulation Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Eli Lilly and Company
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Oral Solid Dosage Pharmaceutical Formulation Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Gilead Sciences
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Oral Solid Dosage Pharmaceutical Formulation Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Merck & Co. Inc.
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Oral Solid Dosage Pharmaceutical Formulation Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Novartis AG
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Oral Solid Dosage Pharmaceutical Formulation Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Novartis AG Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Pfizer Inc.
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Oral Solid Dosage Pharmaceutical Formulation Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 AbbVie Inc.
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Oral Solid Dosage Pharmaceutical Formulation Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Boehringer Ingelheim GmbH
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Oral Solid Dosage Pharmaceutical Formulation Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Hoffman-La-Roche Ltd.
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Oral Solid Dosage Pharmaceutical Formulation Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Johnson & Johnson
    6.12 Biogen Inc.
    6.13 Bayer AG
    6.14 Teva Pharmaceticals
    6.15 Amgen Inc.
    6.16 Takeda Pharmaceutical Company Ltd.
    6.17 Otsuka Pharmaceutical Co., Ltd.
    6.18 Shire Plc.
    6.19 Celgene Corporation
    6.20 Astellas Pharma Inc.

7 Oral Solid Dosage Pharmaceutical Formulation Manufacturing Cost Analysis
    7.1 Oral Solid Dosage Pharmaceutical Formulation Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Oral Solid Dosage Pharmaceutical Formulation

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Oral Solid Dosage Pharmaceutical Formulation Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Oral Solid Dosage Pharmaceutical Formulation Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2017-2022)
    11.1 EMEA Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Oral Solid Dosage Pharmaceutical Formulation Price and Trend Forecast (2017-2022)
    11.2 EMEA Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Type (2017-2022)
    11.7 EMEA Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer


List of Tables and Figures

    Figure Product Picture of Oral Solid Dosage Pharmaceutical Formulation
    Figure EMEA Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Type (2012-2022)
    Figure EMEA Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type (Product Category) in 2016
    Figure Capsules Product Picture
    Figure Powders Product Picture
    Figure Tablets Product Picture
    Figure EMEA Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Application (2012-2022)
    Figure EMEA Sales Market Share of Oral Solid Dosage Pharmaceutical Formulation by Application in 2016
    Figure Hospitals Examples
    Table Key Downstream Customer in Hospitals
    Figure Clinics Examples
    Table Key Downstream Customer in Clinics
    Figure Other Examples
    Table Key Downstream Customer in Other
    Figure EMEA Oral Solid Dosage Pharmaceutical Formulation Market Size (Million USD) by Region (2012-2022)
    Figure Europe Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Europe Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) Status and Forecast by Countries
    Figure Middle East Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Middle East Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) Status and Forecast by Countries
    Figure Africa Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Africa Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) Status and Forecast by Countries
    Figure EMEA Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Growth Rate (2012-2022)
    Figure EMEA Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)
    Figure EMEA Oral Solid Dosage Pharmaceutical Formulation Market Major Players Product Sales Volume (K MT) (2012-2017)
    Table EMEA Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) of Major Players (2012-2017)
    Table EMEA Oral Solid Dosage Pharmaceutical Formulation Sales Share by Players (2012-2017)
    Figure 2016 Oral Solid Dosage Pharmaceutical Formulation Sales Share by Players
    Figure 2017 Oral Solid Dosage Pharmaceutical Formulation Sales Share by Players
    Figure EMEA Oral Solid Dosage Pharmaceutical Formulation Market Major Players Product Revenue (Million USD) (2012-2017)
    Table EMEA Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) by Players (2012-2017)
    Table EMEA Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Players (2012-2017)
    Table 2016 EMEA Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Players
    Table 2017 EMEA Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Players
    Table EMEA Oral Solid Dosage Pharmaceutical Formulation Sale Price (USD/MT) by Players (2012-2017)
    Table EMEA Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Market Share by Type (2012-2017)
    Table EMEA Oral Solid Dosage Pharmaceutical Formulation Sales Share by Type (2012-2017)
    Figure Sales Market Share of Oral Solid Dosage Pharmaceutical Formulation by Type (2012-2017)
    Figure EMEA Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Type (2012-2017)
    Table EMEA Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Market Share by Type (2012-2017)
    Table EMEA Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of Oral Solid Dosage Pharmaceutical Formulation by Type in 2016
    Table EMEA Oral Solid Dosage Pharmaceutical Formulation Sale Price (USD/MT) by Type (2012-2017)
    Table EMEA Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Market Share by Application (2012-2017)
    Table EMEA Oral Solid Dosage Pharmaceutical Formulation Sales Share by Application (2012-2017)
    Figure Sales Market Share of Oral Solid Dosage Pharmaceutical Formulation by Application (2012-2017)
    Figure EMEA Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application in 2016
    Table EMEA Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Market Share by Region (2012-2017)
    Table EMEA Oral Solid Dosage Pharmaceutical Formulation Sales Share by Region (2012-2017)
    Figure Sales Market Share of Oral Solid Dosage Pharmaceutical Formulation by Region (2012-2017)
    Figure EMEA Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in 2016
    Table EMEA Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Market Share by Region (2012-2017)
    Table EMEA Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Region (2012-2017)
    Figure Revenue Market Share of Oral Solid Dosage Pharmaceutical Formulation by Region (2012-2017)
    Figure EMEA Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share Regions in 2016
    Table EMEA Oral Solid Dosage Pharmaceutical Formulation Sales Price (USD/MT) by Region (2012-2017)
    Figure Europe Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure Europe Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2012-2017)
    Table Europe Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) by Type (2012-2017)
    Table Europe Oral Solid Dosage Pharmaceutical Formulation Market Share by Type (2012-2017)
    Figure Europe Oral Solid Dosage Pharmaceutical Formulation Market Share by Type in 2016
    Table Europe Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) by Application (2012-2017)
    Table Europe Oral Solid Dosage Pharmaceutical Formulation Market Share by Application (2012-2017)
    Figure Europe Oral Solid Dosage Pharmaceutical Formulation Market Share by Application in 2016
    Table Europe Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) by Countries (2012-2017)
    Table Europe Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Countries (2012-2017)
    Figure Europe Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Countries (2012-2017)
    Figure Europe Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Countries in 2016
    Table Europe Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) by Countries (2012-2017)
    Table Europe Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries (2012-2017)
    Figure Europe Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries (2012-2017)
    Figure Europe Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries in 2016
    Figure Germany Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure France Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure UK Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure Russia Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure Italy Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure Benelux Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure Middle East Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure Middle East Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2017)
    Table Middle East Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) by Type (2012-2017)
    Table Middle East Oral Solid Dosage Pharmaceutical Formulation Market Share by Type (2012-2017)
    Figure Middle East Oral Solid Dosage Pharmaceutical Formulation Market Share by Type (2012-2017)
    Table Middle East Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) by Applications (2012-2017)
    Table Middle East Oral Solid Dosage Pharmaceutical Formulation Market Share by Applications (2012-2017)
    Figure Middle East Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application in 2016
    Table Middle East Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Countries (2012-2017)
    Table Middle East Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Countries (2012-2017)
    Figure Middle East Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Countries in 2016
    Table Middle East Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) by Countries (2012-2017)
    Table Middle East Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries (2012-2017)
    Figure Middle East Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries (2012-2017)
    Figure Middle East Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries in 2016
    Figure Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure Israel Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure UAE Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure Iran Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure Africa Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure Africa Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2017)
    Table Africa Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) by Type (2012-2017)
    Table Africa Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Type (2012-2017)
    Figure Africa Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Type (2012-2017)
    Figure Africa Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Type in 2016
    Table Africa Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) by Application (2012-2017)
    Table Africa Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application (2012-2017)
    Figure Africa Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application (2012-2017)
    Table Africa Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Countries (2012-2017)
    Table Africa Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Countries (2012-2017)
    Figure Africa Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Countries (2012-2017)
    Figure Africa Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Countries in 2016
    Table Africa Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) by Countries (2012-2017)
    Table Africa Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries (2012-2017)
    Figure Africa Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries (2012-2017)
    Figure Africa Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries in 2016
    Figure South Africa Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure Nigeria Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure Egypt Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure Algeria Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Table AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Basic Information List
    Table AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in EMEA (2012-2017)
    Figure AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in EMEA (2012-2017)
    Table Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Basic Information List
    Table Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in EMEA (2012-2017)
    Figure Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in EMEA (2012-2017)
    Table Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Basic Information List
    Table Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in EMEA (2012-2017)
    Figure Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in EMEA (2012-2017)
    Table Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Basic Information List
    Table Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in EMEA (2012-2017)
    Figure Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in EMEA (2012-2017)
    Table Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Basic Information List
    Table Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in EMEA (2012-2017)
    Figure Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in EMEA (2012-2017)
    Table Novartis AG Oral Solid Dosage Pharmaceutical Formulation Basic Information List
    Table Novartis AG Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Novartis AG Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure Novartis AG Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in EMEA (2012-2017)
    Figure Novartis AG Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in EMEA (2012-2017)
    Table Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Basic Information List
    Table Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in EMEA (2012-2017)
    Figure Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in EMEA (2012-2017)
    Table AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Basic Information List
    Table AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in EMEA (2012-2017)
    Figure AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in EMEA (2012-2017)
    Table Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Basic Information List
    Table Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in EMEA (2012-2017)
    Figure Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in EMEA (2012-2017)
    Table Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Basic Information List
    Table Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
    Figure Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in EMEA (2012-2017)
    Figure Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in EMEA (2012-2017)
    Table Johnson & Johnson Oral Solid Dosage Pharmaceutical Formulation Basic Information List
    Table Biogen Inc. Oral Solid Dosage Pharmaceutical Formulation Basic Information List
    Table Bayer AG Oral Solid Dosage Pharmaceutical Formulation Basic Information List
    Table Teva Pharmaceticals Oral Solid Dosage Pharmaceutical Formulation Basic Information List
    Table Amgen Inc. Oral Solid Dosage Pharmaceutical Formulation Basic Information List
    Table Takeda Pharmaceutical Company Ltd. Oral Solid Dosage Pharmaceutical Formulation Basic Information List
    Table Otsuka Pharmaceutical Co., Ltd. Oral Solid Dosage Pharmaceutical Formulation Basic Information List
    Table Shire Plc. Oral Solid Dosage Pharmaceutical Formulation Basic Information List
    Table Celgene Corporation Oral Solid Dosage Pharmaceutical Formulation Basic Information List
    Table Astellas Pharma Inc. Oral Solid Dosage Pharmaceutical Formulation Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Oral Solid Dosage Pharmaceutical Formulation
    Figure Manufacturing Process Analysis of Oral Solid Dosage Pharmaceutical Formulation
    Figure Oral Solid Dosage Pharmaceutical Formulation Industrial Chain Analysis
    Table Raw Materials Sources of Oral Solid Dosage Pharmaceutical Formulation Major Manufacturers in 2016
    Table Major Buyers of Oral Solid Dosage Pharmaceutical Formulation
    Table Distributors/Traders List
    Figure EMEA Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate Forecast (2017-2022)
    Figure EMEA Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate Forecast (2017-2022)
    Figure EMEA Oral Solid Dosage Pharmaceutical Formulation Price (USD/MT) and Trend Forecast (2017-2022)
    Table EMEA Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) Forecast by Region (2017-2022)
    Figure EMEA Oral Solid Dosage Pharmaceutical Formulation Sales Market Share Forecast by Region (2017-2022)
    Table EMEA Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) Forecast by Region (2017-2022)
    Figure EMEA Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share Forecast by Region (2017-2022)
    Table Europe Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) Forecast by Countries (2017-2022)
    Figure Europe Oral Solid Dosage Pharmaceutical Formulation Sales Market Share Forecast by Countries (2017-2022)
    Table Europe Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) Forecast by Countries (2017-2022)
    Figure Europe Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share Forecast by Countries (2017-2022)
    Table Middle East Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) Forecast by Countries (2017-2022)
    Figure Middle East Oral Solid Dosage Pharmaceutical Formulation Sales Market Share Forecast by Countries (2017-2022)
    Table Middle East Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) Forecast by Countries (2017-2022)
    Figure Middle East Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share Forecast by Countries (2017-2022)
    Table Africa Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) Forecast by Countries (2017-2022)
    Figure Africa Oral Solid Dosage Pharmaceutical Formulation Sales Market Share Forecast by Countries (2017-2022)
    Table Africa Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) Forecast by Countries (2017-2022)
    Figure Africa Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share Forecast by Countries (2017-2022)
    Table EMEA Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) Forecast by Type (2017-2022)
    Figure EMEA Oral Solid Dosage Pharmaceutical Formulation Sales Market Share Forecast by Type (2017-2022)
    Table EMEA Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) Forecast by Application (2017-2022)
    Figure EMEA Oral Solid Dosage Pharmaceutical Formulation Sales Market Share Forecast by Application (2017-2022)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

 



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global coated fabrics market size forecast is estimated at USD 22.57 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing production of seat covers & airbags for automobile applications is likely to favor market growth.

Read More...

Global automotive coatings market size is likely to be valued at USD 27.7 billion by 2022; as per a new research report by Radiant Insights, Inc. Vehicle aesthetics, UV radiation and temperature variation protection and enhance durability are certain

Read More...

Global commercial drone market size is estimated to reach USD 2,069.6 million by 2022, as per a new research report by Radiant Insights, Inc. Increasing application of these machines in various industry sectors such as military, agriculture and energ

Read More...

Global 3D scanning market is expected to be valued at USD 4,900.7 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing need for speedy and precise results with high efficiency is anticipated to drive the industry. 3D

Read More...

Global lignin market size is expected to exceed USD 6 billion by 2022, growing at 4.9% from 2015 to 2022. Rising demand for animal feed and potential as a feedstock substitute to crude oil are expected to drive lignin market demand over the forecast

Read More...
Choose License Type
Single User - US $4000
Multi User - US $8000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify